Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.

Welsh P, Doolin O, Willeit P, Packard C, Macfarlane P, Cobbe S, Gudnason V, Di Angelantonio E, Ford I, Sattar N.

Eur Heart J. 2013 Feb;34(6):443-50. doi: 10.1093/eurheartj/ehs239. Epub 2012 Aug 31. Erratum in: Eur Heart J. 2013 Apr;34(15):1094.

2.

N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease.

Wannamethee SG, Welsh P, Lowe GD, Gudnason V, Di Angelantonio E, Lennon L, Rumley A, Whincup PH, Sattar N.

J Am Coll Cardiol. 2011 Jun 28;58(1):56-64. doi: 10.1016/j.jacc.2011.02.041.

3.

NT-proBNP best predictor of cardiovascular events and cardiovascular mortality in secondary prevention in very old age: the Leiden 85-plus Study.

van Peet PG, Drewes YM, de Craen AJ, Gussekloo J, de Ruijter W.

PLoS One. 2013 Nov 21;8(11):e81400. doi: 10.1371/journal.pone.0081400. eCollection 2013.

4.

N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.

Olsen MH, Wachtell K, Nielsen OW, Hall C, Wergeland R, Ibsen H, Kjeldsen SE, Devereux RB, Dahlöf B, Hildebrandt PR.

J Hypertens. 2006 Aug;24(8):1531-9.

PMID:
16877955
5.

N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.

Olsen MH, Hansen TW, Christensen MK, Gustafsson F, Rasmussen S, Wachtell K, Ibsen H, Torp-Pedersen C, Hildebrandt PR.

Eur Heart J. 2007 Jun;28(11):1374-81. Epub 2007 Jan 22.

6.
7.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.

JAMA. 2005 Apr 6;293(13):1609-16.

PMID:
15811980
8.

High-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: a prognostic study within the CLARICOR trial.

Harutyunyan MJ, Mathiasen AB, Winkel P, Gøtze JP, Hansen JF, Hildebrandt P, Jensen GB, Hilden J, Jespersen CM, Kjøller E, Kolmos HJ, Gluud C, Kastrup J; CLARICOR Trial Group.

Scand J Clin Lab Invest. 2011 Feb;71(1):52-62. doi: 10.3109/00365513.2010.538081. Epub 2010 Nov 25.

PMID:
21108561
9.

Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

Daniels LB, Clopton P, deFilippi CR, Sanchez OA, Bahrami H, Lima JA, Tracy RP, Siscovick D, Bertoni AG, Greenland P, Cushman M, Maisel AS, Criqui MH.

Am Heart J. 2015 Dec;170(6):1170-83. doi: 10.1016/j.ahj.2015.09.010. Epub 2015 Sep 28.

PMID:
26678639
10.

Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam study.

Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, Breteler MM, Witteman JC, van den Meiracker AH.

Hypertension. 2010 Mar;55(3):785-91. doi: 10.1161/HYPERTENSIONAHA.109.143313. Epub 2010 Jan 18.

11.
12.

N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study.

Wannamethee SG, Welsh P, Whincup PH, Lennon L, Papacosta O, Sattar N.

Eur J Heart Fail. 2014 Jan;16(1):25-32. doi: 10.1093/eurjhf/hft124. Epub 2013 Dec 3.

13.

Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.

Ahluwalia N, Blacher J, Szabo de Edelenyi F, Faure P, Julia C, Hercberg S, Galan P.

Atherosclerosis. 2013 Jun;228(2):478-84. doi: 10.1016/j.atherosclerosis.2013.03.017. Epub 2013 Mar 26.

PMID:
23582589
14.
15.

N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients.

Duprez DA, Neuhaus J, Tracy R, Kuller LH, Deeks SG, Orkin C, Stoehr A, Woolley IJ, Neaton JD; INSIGHT SMART Group.

AIDS. 2011 Mar 13;25(5):651-7. doi: 10.1097/QAD.0b013e32834404a1.

16.

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Price AH, Welsh P, Weir CJ, Feinkohl I, Robertson CM, Morling JR, McLachlan S, Strachan MW, Sattar N, Price JF.

Diabetologia. 2014 Dec;57(12):2505-12. doi: 10.1007/s00125-014-3375-9. Epub 2014 Sep 18.

PMID:
25231020
17.

Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study.

Daniels LB, Barrett-Connor E, Clopton P, Laughlin GA, Ix JH, Maisel AS.

J Am Coll Cardiol. 2012 Mar 20;59(12):1101-9. doi: 10.1016/j.jacc.2011.11.046.

18.

Amino-Terminal Pro-B-Type Natriuretic Peptide Improves Discrimination for Incident Atherosclerotic Cardiovascular Disease Beyond Ambulatory Blood Pressure in Elderly Men.

Skoglund PH, Höijer J, Ärnlöv J, Zethelius B, Svensson P.

Hypertension. 2015 Sep;66(3):681-6; discussion 445. doi: 10.1161/HYPERTENSIONAHA.115.05717. Epub 2015 Jul 6.

PMID:
26150437
19.

N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.

Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2997-3003. doi: 10.1161/ATVBAHA.111.223669. Epub 2011 Sep 15.

20.

Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.

Karakas M, Jaensch A, Breitling LP, Brenner H, Koenig W, Rothenbacher D.

Clin Chem. 2014 Nov;60(11):1441-9. doi: 10.1373/clinchem.2013.220202. Epub 2014 Aug 19.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk